Cargando…
Physical and cognitive correlates, inflammatory levels, and treatment response in post-COVID-19 first-onset vs. recurrent depressive episodes
Psychiatric symptoms have been frequently reported in patients affected by COVID-19, both as new occurring and recurrences of pre-existing diseases. Depressive symptoms are estimated to affect at least 30% of patients following infection, with specific physical and cognitive features and relevant im...
Autores principales: | Di Nicola, Marco, Pepe, Maria, De Mori, Lorenzo, Ferrara, Ottavia Marianna, Panaccione, Isabella, Sani, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166052/ https://www.ncbi.nlm.nih.gov/pubmed/37154920 http://dx.doi.org/10.1007/s00406-023-01617-7 |
Ejemplares similares
-
Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
por: Di Nicola, Marco, et al.
Publicado: (2023) -
Cognitive impairment in post-covid-19 patients with major depressive episodes – a three-months study on the effect of vortioxetine
por: Di Nicola, M., et al.
Publicado: (2022) -
COVID-19 and New-Onset Psychosis: A Comprehensive Review
por: Moccia, Lorenzo, et al.
Publicado: (2023) -
Social Cognition and Interpersonal Problems in Persistent Depressive Disorder vs. Episodic Depression: The Role of Childhood Maltreatment
por: Struck, Nele, et al.
Publicado: (2021) -
The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies
por: Sani, Gabriele, et al.
Publicado: (2023)